BioCardia, Inc. Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest
BioCardia, Inc. (BCDA) reported Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest of $0 for the 12-month period ending 2013-12-31, per its 10-K filed 2014-03-24.
Discontinued › Income Statement › Net Income
us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax · last filed 2014-03-24
- BioCardia, Inc. income (loss) from discontinued operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2012-12-31 was $104.00K.
- BioCardia, Inc. income (loss) from discontinued operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2012-09-30 was $0.00.
- BioCardia, Inc. income (loss) from discontinued operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2012-06-30 was $0.00.
- BioCardia, Inc. income (loss) from discontinued operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2012-03-31 was $0.00.
- BioCardia, Inc. income (loss) from discontinued operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2013 was $0.00, a 100.00% decline from fiscal 2012.
- BioCardia, Inc. income (loss) from discontinued operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2012 was $104.00K.
- BioCardia, Inc. income (loss) from discontinued operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2011 was -$1.55M.
- BioCardia, Inc. income (loss) from discontinued operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2010 was -$10.95M.
| Period end | Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 month | Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 month | Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 month | Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2013-12-31 | $0.00 10-K · filed 2014-03-24 | |||
| 2012-12-31 | $104.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-24 | $104.00K derived: sum of 2 quarters · filed 2014-03-24 | $104.00K derived: sum of 3 quarters · filed 2014-03-24 | $104.00K 10-K · filed 2014-03-24 |
| 2012-09-30 | $0.00 10-Q · filed 2012-11-08 | $0.00 derived: sum of 2 quarters · filed 2012-11-08 | $0.00 10-Q · filed 2012-11-08 | -$134.00K derived: sum of 4 quarters · filed 2013-03-22 |
| 2012-06-30 | $0.00 10-Q · filed 2012-08-10 | $0.00 10-Q · filed 2012-08-10 | -$134.00K derived: sum of 3 quarters · filed 2013-03-22 | -$186.00K derived: sum of 4 quarters · filed 2013-03-22 |
| 2012-03-31 | $0.00 10-Q · filed 2012-05-15 | -$134.00K derived: sum of 2 quarters · filed 2013-03-22 | -$186.00K derived: sum of 3 quarters · filed 2013-03-22 | -$1.36M derived: sum of 4 quarters · filed 2013-03-22 |
| 2011-12-31 | -$134.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-22 | -$186.00K derived: sum of 2 quarters · filed 2013-03-22 | -$1.36M derived: sum of 3 quarters · filed 2013-03-22 | -$1.55M 10-K · filed 2013-03-22 |
| 2011-09-30 | -$52.00K 10-Q · filed 2012-11-08 | -$1.22M derived: sum of 2 quarters · filed 2012-11-08 | -$1.42M 10-Q · filed 2012-11-08 | -$1.75M derived: sum of 4 quarters · filed 2012-11-08 |
| 2011-06-30 | -$1.17M 10-Q · filed 2012-08-10 | -$1.37M 10-Q · filed 2012-08-10 | -$1.70M derived: sum of 3 quarters · filed 2012-08-10 | -$9.70M derived: sum of 4 quarters · filed 2012-08-10 |
| 2011-03-31 | -$196.00K 10-Q · filed 2012-05-15 | -$526.00K derived: sum of 2 quarters · filed 2012-05-15 | -$8.53M derived: sum of 3 quarters · filed 2012-05-15 | -$9.88M derived: sum of 4 quarters · filed 2012-05-15 |
| 2010-12-31 | -$330.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-29 | -$8.34M derived: sum of 2 quarters · filed 2012-03-29 | -$9.68M derived: sum of 3 quarters · filed 2012-03-29 | -$10.95M 10-K · filed 2012-03-29 |
| 2010-09-30 | -$8.01M 10-Q · filed 2011-11-15 | -$9.35M derived: sum of 2 quarters · filed 2011-11-17 | -$10.62M 10-Q · filed 2011-11-15 | |
| 2010-06-30 | -$1.35M 10-Q/A · filed 2011-11-17 | -$2.62M 10-Q/A · filed 2011-11-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |